A Canadian drug distributor faces potential jail time and forfeiture of at least $78 million in proceeds after being accused of selling drugs with unauthorized labeling and unknown manufacturers to customers in the United States. To evade inspection, shipments were valued under $2,000 to avoid formal entry. The company continued to undervalue these goods despite warnings from their customs broker. Â